Cargando…
Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation
Human term placenta and other postpartum-derived biological tissues are promising sources of perinatal cells with unique stem cell properties. Among the massive current research on stem cells, one medical focus on easily available stem cells is to exploit them in the design of immunotherapy protocol...
Autores principales: | Paris, Francesca, Pizzuti, Valeria, Marrazzo, Pasquale, Pession, Andrea, Alviano, Francesco, Bonsi, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738084/ https://www.ncbi.nlm.nih.gov/pubmed/36498923 http://dx.doi.org/10.3390/ijms232314597 |
Ejemplares similares
-
Mitigating Oxidative Stress in Perinatal Cells: A Critical Step toward an Optimal Therapeutic Use in Regenerative Medicine
por: Pizzuti, Valeria, et al.
Publicado: (2023) -
Characterization of Perinatal Stem Cell Spheroids for the Development of Cell Therapy Strategy
por: Paris, Francesca, et al.
Publicado: (2023) -
Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome
por: Marrazzo, Pasquale, et al.
Publicado: (2021) -
Never say never…
por: Schmidt, Laura A.
Publicado: (2021) -
Never say never
por: Westgarth, David
Publicado: (2021)